← Main Index Directory
BPC-157 Assay Protocol
In-Vitro ArchitectureDelivery & Half-Life Parameters
Validated Mapping Vector: Subcutaneous local injections provide targeted site accuracy. Unique gastric sequence allows high stability in oral administration.
Biological Half-Life Metric: Extremely short in blood plasma (~4 hours).
Recommended In-Vitro Dosing Architecture
Standard systemic parameter is 250mcg to 500mcg injected twice daily (BID), ideally as close to the target trauma site as possible.
Standard Target Observation Timelines
Standard testing intervals run from 4 to 8 weeks, followed by a mandatory 2-week baseline pause.